{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:28:10Z","timestamp":1777447690504,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.contraception.2014.11.004","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T11:38:47Z","timestamp":1416224327000},"page":"178-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan"],"prefix":"10.1016","volume":"91","author":[{"given":"Ingrida","family":"Platais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Tsereteli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodica","family":"Comendant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilfuza","family":"Kurbanbekova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.contraception.2014.11.004_bb0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2012.06.011","article-title":"First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review","volume":"87","author":"Raymond","year":"2013","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2014.11.004_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.contraception.2005.03.011","article-title":"Safety of mifepristone abortions in clinical use","volume":"72","author":"Henderson","year":"2005","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2014.11.004_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa0809146","article-title":"Rates of serious infection after changes in regimens for medical abortion","volume":"361","author":"Fjerstad","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.contraception.2014.11.004_bb0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e3182755763","article-title":"Significant adverse events and outcomes after medical abortion","volume":"121","author":"Cleland","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2014.11.004_bb0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.contraception.2006.11.011","article-title":"Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research","volume":"75","author":"Clark","year":"2007","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2014.11.004_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2307\/2950827","article-title":"The acceptability of medical abortion in China, Cuba and India","volume":"23","author":"Winikoff","year":"1997","journal-title":"Int Fam Plan Perspect"},{"issue":"4","key":"10.1016\/j.contraception.2014.11.004_bb0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bpobgyn.2010.02.006","article-title":"Medical and surgical options for induced abortion in first trimester","volume":"24","author":"Hamoda","year":"2010","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.contraception.2014.11.004_bb0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.contraception.2011.05.019","article-title":"Can women accurately assess the outcome of medical abortion based on symptoms alone?","volume":"85","author":"Jackson","year":"2012","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2014.11.004_bb0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jfprhc-2011-100149","article-title":"Comparison of unscheduled re-attendance and contraception at discharge, among women having the final stage of early medical abortion at home and those remaining in hospital","volume":"38","author":"Astle","year":"2012","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"4","key":"10.1016\/j.contraception.2014.11.004_bb0050","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/00016340701203632","article-title":"Risk factors for unsuccessful medical abortion with mifepristone and misoprostol","volume":"86","author":"Haimov-Kochman","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.contraception.2014.11.004_bb0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2011.09.007","article-title":"Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment","volume":"85","author":"Horning","year":"2012","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2014.11.004_bb0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.contraception.2012.06.005","article-title":"Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study","volume":"86","author":"Blum","year":"2012","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2014.11.004_bb0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijgo.2012.11.022","article-title":"Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up","volume":"121","author":"Lynd","year":"2013","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.contraception.2014.11.004_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/AOG.0000000000000050","article-title":"Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam: a randomized controlled trial","volume":"123","author":"Ngoc","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.contraception.2014.11.004_bb0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/AOG.0b013e3181c996f3","article-title":"Alternatives to a routine follow-up visit for early medical abortion","volume":"115","author":"Clark","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.contraception.2014.11.004_bb0080","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.contraception.2010.05.013","article-title":"Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days\u2019 LMP: a randomized controlled trial","volume":"82","author":"Raghavan","year":"2010","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2014.11.004_bb0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/13625187.2013.763225","article-title":"Acceptability and feasibility of the use of 400 mcg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan","volume":"18","author":"Raghavan","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.contraception.2014.11.004_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.contraception.2014.03.016","article-title":"RU OK? The acceptability and feasibility of remote technologies for follow-up after early medical abortion","volume":"90","author":"Bracken","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.11.004_bb0100","series-title":"Safe abortion: technical and policy guidance for health systems","year":"2012"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414007756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414007756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T14:31:26Z","timestamp":1538058686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782414007756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0010782414007756"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2014.11.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2014.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}